Pharmacophore-Based Screening for the Successful Identification of Bio-Active Natural Products

Pharmacophore-Based Screening for the Successful Identification of Bio-Active Natural Products

We report on the impact of pharmacophore-based virtual screening in the field of drug discovery from natural products. Confronted by an increasing number of secondary metabolites and an increasing number of biomolecular targets relevant in the therapy of human disorders, there is clearly t...

Full description

Bibliographic Details
Main Authors:	Thierry Langer, Christian Laggner, Judith M. Rollinger, Hermann Stuppner
Format:	Article
Language:	deu
Published:	Swiss Chemical Society 2007-06-01
Series:	CHIMIA
Subjects:	Natural products Pharmacophores Virtual screening
Online Access:	https://chimia.ch/chimia/article/view/4338

Similar Items

Greedy 3-Point Search (G3PS)—A Novel Algorithm for Pharmacophore Alignment
by: Christian Permann, et al.
Published: (2021-11-01)

Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
by: Timur I. Madzhidov, et al.
Published: (2020-01-01)

Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study
by: Salvatore Galati, et al.
Published: (2022-06-01)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
by: Teresa Kaserer, et al.
Published: (2015-12-01)

In Silico Workflow for the Discovery of Natural Products Activating the G Protein-Coupled Bile Acid Receptor 1
by: Benjamin Kirchweger, et al.
Published: (2018-07-01)

Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation
by: Stefan Michael Kohlbacher, et al.
Published: (2022-09-01)

Drug Design by Pharmacophore and Virtual Screening Approach
by: Deborah Giordano, et al.
Published: (2022-05-01)

Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
by: Vibhu Jha, et al.
Published: (2020-12-01)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
by: Lamees Hegazy, et al.
Published: (2022-02-01)

Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants
by: Ntie-Kang F, et al.
Published: (2016-07-01)

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
by: Samo Guzelj, et al.
Published: (2022-07-01)

Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
by: Congshan Liu, et al.
Published: (2020-03-01)

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors
by: Yunjiang Zhou, et al.
Published: (2019-11-01)

Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
by: Laura Gallego-Yerga, et al.
Published: (2021-01-01)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01)

Identification of BACE-1 Inhibitors against Alzheimer’s Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach
by: Kumarappan Chidambaram
Published: (2023-04-01)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
by: Yi Zhang, et al.
Published: (2020-09-01)

Pharmacophore-Based Virtual Screening of Novel GSTP1-1 Inhibitors
by: Kayhan Bolelli, et al.
Published: (2018-11-01)

Selection of Efficient Inhibitors for Caspas-9 according to Structure-Based Pharmacophore Screening Strategy and Molecular Dynamics Simulations
by: Samira Ansari, et al.
Published: (2020-01-01)

Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
by: F. A. Dain Md Opo, et al.
Published: (2022-10-01)

Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach
by: Stefano Alcaro, et al.
Published: (2013-09-01)

Identification of Novel AXL Kinase Inhibitors Using Ligand-Based Pharmacophore Screening and Molecular Dynamics Simulations
by: Lavanya Nagamalla, et al.
Published: (2022-08-01)

Mind the Gap—Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence
by: Theresa Noonan, et al.
Published: (2022-10-01)

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
by: Zixiao Wang, et al.
Published: (2023-08-01)

Pharmacophore modeling for the identification of small-molecule inhibitors of TACE
by: Liu, Li-Juan, et al.
Published: (2016)

Pharmacophore-based screening of differentially-expressed PGF, DDIT4, COMP and CHI3L1 from hMSC cell lines reveals five novel therapeutic compounds for primary osteoporosis
by: Catherine Jessica Lai
Published: (2016-06-01)

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products
by: Lianxiang Luo, et al.
Published: (2021-12-01)

Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
by: Atatreh N, et al.
Published: (2018-11-01)

Identification of novel anti-cryptosporidial inhibitors through a combined approach of pharmacophore modeling, virtual screening, and molecular docking
by: Kalpana Katiyar, et al.
Published: (2021-01-01)

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
by: Marwa A. Fouad, et al.
Published: (2024-02-01)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
by: Nizar M. Mhaidat, et al.
Published: (2013-05-01)

Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth
by: Chia-Wei Weng, et al.
Published: (2022-03-01)

Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics
by: Shraddha Parate, et al.
Published: (2021-04-01)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
by: Alina Kutlushina, et al.
Published: (2018-11-01)

Hypouricemic effect of Grifola frondosa on hyperuricemic mice and virtual screening of bioactives by 3D QSAR pharmacophore modeling
by: Tianqiao Yong, et al.
Published: (2018-01-01)

Ligand-based pharmacophore modelling, structure optimisation, and biological evaluation for the identification of 2-heteroarylthio-N-arylacetamides as novel HSP90 C-terminal inhibitors
by: Yajun Liu, et al.
Published: (2024-12-01)

A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations
by: Ni Made Pitri Susanti, et al.
Published: (2021-12-01)

Characterization of fenugreek and its natural compounds targeting AKT-1 protein in cancer: Pharmacophore, virtual screening, and MD simulation techniques
by: Hafiz Muhammad Ahmad, et al.
Published: (2022-08-01)

Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release
by: Erika Cione, et al.
Published: (2021-01-01)